Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches

By Lynch Caitlin  

Pharmaceutical Research, Vol. 30, Iss. 2, 2013-02 ,pp. : 489-501

Springer Publishing Company

Access to resources Recommend Favorite

FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA

By  

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-04 ,pp. : 2164-2173

Bentham Science Publishers

Access to resources Recommend Favorite

FDA-approved phenylephrine decongestant dose questioned

By  

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Coverage Policy and Use Beyond the FDA-Approved Label

By McGivney William T.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 99-101

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite